Effects of Ipsapirone in Healthy Subjects: a Dose-response Study

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1994 Feb 1

PMID 7846198

Citations 2

Authors

R S Kahn

R Trestman

B A Lawlor

S Gabriel

M Davidson

L Siever

Affiliations

Soon will be listed here.

Abstract

A dose-response study of ipsapirone (IPS), a 5HT1a partial agonist, was conducted in healthy male subjects. IPS was administered in doses of 5, 10 and 20 mg PO in a placebo-controlled, double-blind design to 15 subjects on 4 test days separated by at least 3 days. Oral temperature, ACTH, cortisol, prolactin, blood pressure, pulse rate and behavioral variables were assessed every 30 min for 3 h after administration of tablets (at 10:00 A.M.). IPS at 20 mg significantly decreased temperature and increased cortisol levels. Although IPS increased ACTH levels at 20 mg, this effect was variable and not significant. IPS did not affect prolactin levels nor did it have any behavioral effects. Although 20 mg IPS decreased blood pressure and pulse rate in one subject, overall it had no significant effect on these parameters. IPS at 20 mg PO appears a useful probe to test 5HT1a function when temperature and cortisol are used as response variables. These results replicate earlier studies on the effect of IPS in healthy human subjects.

Citing Articles

Childhood serotonergic function and early adult outcomes in youth with ADHD: A 15-year follow-up study.

Ivanov I, Flory J, Newcorn J, Halperin J Eur Neuropsychopharmacol. 2018; 28(12):1429-1438.

PMID: 30454909 PMC: 6296770. DOI: 10.1016/j.euroneuro.2018.09.001.

The antagonism of ipsapirone induced biobehavioral responses by +/- pindolol in high and low impulsives.

Hennig J, Opper C, Huwe S, Netter P J Neural Transm (Vienna). 1997; 104(10):1027-35.

PMID: 9503255 DOI: 10.1007/BF01273316.

References

Gilbert F, Brazell C, Tricklebank M, Stahl S . Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol. 1988; 147(3):431-9. DOI: 10.1016/0014-2999(88)90178-1. View

Mueller E, Murphy D, Sunderland T . Neuroendocrine effects of M-chlorophenylpiperazine, a serotonin agonist, in humans. J Clin Endocrinol Metab. 1985; 61(6):1179-84. DOI: 10.1210/jcem-61-6-1179. View

Veldhuis J, Iranmanesh A, Johnson M, Lizarralde G . Twenty-four-hour rhythms in plasma concentrations of adenohypophyseal hormones are generated by distinct amplitude and/or frequency modulation of underlying pituitary secretory bursts. J Clin Endocrinol Metab. 1990; 71(6):1616-23. DOI: 10.1210/jcem-71-6-1616. View

Mueller E, Murphy D, Sunderland T . Further studies of the putative serotonin agonist, m-chlorophenylpiperazine: evidence for a serotonin receptor mediated mechanism of action in humans. Psychopharmacology (Berl). 1986; 89(3):388-91. DOI: 10.1007/BF00174380. View

Hollander E, DeCaria C, Gully R, Nitescu A, Suckow R, Gorman J . Effects of chronic fluoxetine treatment on behavioral and neuroendocrine responses to meta-chlorophenylpiperazine in obsessive-compulsive disorder. Psychiatry Res. 1991; 36(1):1-17. DOI: 10.1016/0165-1781(91)90113-4. View

Lesch K, Rupprecht R, Poten B, Muller U, Sohnle K, Fritze J . Endocrine responses to 5-hydroxytryptamine-1A receptor activation by ipsapirone in humans. Biol Psychiatry. 1989; 26(2):203-5. DOI: 10.1016/0006-3223(89)90024-3. View

Kahn R, Wetzler S, van Praag H, Asnis G, Strauman T . Behavioral indications for serotonin receptor hypersensitivity in panic disorder. Psychiatry Res. 1988; 25(1):101-4. DOI: 10.1016/0165-1781(88)90163-1. View

Meltzer H, Robertson A, TRICOU B, Lowy M, Perline R . Effect of 5-hydroxytryptophan on serum cortisol levels in major affective disorders. I. Enhanced response in depression and mania. Arch Gen Psychiatry. 1984; 41(4):366-74. DOI: 10.1001/archpsyc.1984.01790150056009. View

Beneke M, Wingender W, Horstmann R, Konrad-Dalhoff I, Weber H, Kuhlmann J . Neuroendocrine effects of ipsapirone on the hypothalamic-pituitary adrenal axis: CRF, ACTH and cortisol in healthy volunteers. Eur J Clin Pharmacol. 1992; 42(2):163-9. DOI: 10.1007/BF00278478. View

10.

Heninger G, Charney D, Sternberg D . Serotonergic function in depression. Prolactin response to intravenous tryptophan in depressed patients and healthy subjects. Arch Gen Psychiatry. 1984; 41(4):398-402. DOI: 10.1001/archpsyc.1984.01790150088012. View

11.

Lesch K, Hoh A, Wiesmann M, Osterheider M, Schulte H . 5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls. Arch Gen Psychiatry. 1991; 48(6):540-7. DOI: 10.1001/archpsyc.1991.01810300052007. View

12.

Mandal A, Zhong P, Kellar K, GILLIS R . Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors. J Cardiovasc Pharmacol. 1990; 15 Suppl 7:S49-60. View

13.

Van de Kar L, Lorens S, Urban J, Bethea C . Effect of selective serotonin (5-HT) agonists and 5-HT2 antagonist on prolactin secretion. Neuropharmacology. 1989; 28(3):299-305. DOI: 10.1016/0028-3908(89)90107-x. View

14.

Harrington M, Zhong P, Garlow S, Ciaranello R . Molecular biology of serotonin receptors. J Clin Psychiatry. 1992; 53 Suppl:8-27. View

15.

Dabire H, LAUBIE M, Schmitt H . Hypotensive effects of 5-HT1A receptor agonists on the ventrolateral medullary pressor area in dogs. J Cardiovasc Pharmacol. 1990; 15 Suppl 7:S61-7. View

16.

Owens M, Edwards E, Nemeroff C . Effects of 5-HT1A receptor agonists on hypothalamo-pituitary-adrenal axis activity and corticotropin-releasing factor containing neurons in the rat brain. Eur J Pharmacol. 1990; 190(1-2):113-22. DOI: 10.1016/0014-2999(90)94118-h. View

17.

Siever L, Murphy D, Slater S, de la Vega E, Lipper S . Plasma prolactin changes following fenfluramine in depressed patients compared to controls: an evaluation of central serotonergic responsivity in depression. Life Sci. 1984; 34(11):1029-39. DOI: 10.1016/0024-3205(84)90016-x. View

18.

Gilbert F, Dourish C, Brazell C, McClue S, Stahl S . Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats. Psychoneuroendocrinology. 1988; 13(6):471-8. DOI: 10.1016/0306-4530(88)90032-7. View

19.

Targum S, Marshall L . Fenfluramine provocation of anxiety in patients with panic disorder. Psychiatry Res. 1989; 28(3):295-306. DOI: 10.1016/0165-1781(89)90210-2. View

20.

Anderson I, Cowen P . Effect of pindolol on endocrine and temperature responses to buspirone in healthy volunteers. Psychopharmacology (Berl). 1992; 106(3):428-32. DOI: 10.1007/BF02245430. View